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KAJIAN UNTUK MENENTUKAN FREKUENSI KEJADIAN POLIMORFISME 
CALON-CALON GEN BAGI HIPERTENSI Dl KALANGAN 
MASYARAKAT MELAYU 
ABSTRAK 
Hipertensi atau peningkatan tekanan darah arteri adalah merupakan masalah 
kesihatan umum yang penting dan adalah merupakan faktor risiko yang utama bagi 
kebanyakkan kecacatan dan kematian kardiovaskular. Tekanan darah dikawalatur oleh 
pelbagai mekanisme yang melibatkan beberapa lokus genetik dan faktor-faktor 
persekitaran. "Hipertensi essensial" di kalangan manusia adalah gangguan pelbagai 
faktor yang disebabkan oleh interaksi di antara kedua-dua faktor genetik dan faktor 
persekitaran. Penyelidikan berkaitan dengan hipertensi essensial di kalangan manusia 
berasaskan genetik molekul telahpun dijalankan beberapa tahun yang lalu. Kajian ini 
bertujuan untuk mengkaji calon-calon gen tertentu yang mungkin menyumbang kepada 
penghasilan tekanan darah yang tidak normal disebabkan oleh kesannya ke atas 
sistem kardiovaskular. 
Di antara pelbagai calon-calon gen yang tersenarai dan diwartakan 
hubungkaitnya dengan hipertensi, tiga daripadanya telah dipilih dan perkaitannya 
dengan kejadian hipertensi dikalangan masyarakat Melayu dikaji di dalam tesis ini. 
Frekuensi bagi varian polimorfik bagi calon-calon gen yang spesifik ini juga ditentukan. 
Polimorfisme yang dikaji adalah T594M bagi gen epithelial sodium channel (ENaC), 
M235T bagi gen angiotensinogen (AGT) dan G894T bagi gen endothelial nitric oxide 
synthase (eNOS). Dalam kajian ini sejumlah 398 sampel DNA dianalisa daripada 
seramai 200 orang penghidap hipertensi dan 198 orang subjek kawalan yang mana 
umur dan jantina mereka telah dipadankan. Kesemua subjek yang terlibat di dalam 
kajian ini adalah merupakan Melayu tulen bagi tiga generasi berturut-turut. 
xvii 
Taburan frekuensi bagi genotip M235T di dalam populasi adalah 3.5% bagi 
homozigos liar (MM), 30.4% bagi heterozigos (MT) dan 66.1% bagi homozigos mutan 
(TT). Frekuensi bagi genotip TT adalah sebanyak 63.5% bagi hipertensi dan 68.7% 
bagi kawalan. Frekuensi bagi aiel M235 dan T235 adalah 20.0% dan 80.0% dikalangan 
penghidap hipertensi dan 17.4% dan 82.6% dikalangan subjek kawalan. Tiada 
perbezaan yang signifikan dapat dicerap pada frekuensi genotip (x2=1.30, p=0.52) dan 
aiel <l=0.87, p=0.35) di antara kedua-dua kumpulan kajian. Risiko bandingan bagi 
hipertensi adalah sebanyak 1.01 bagi subjek yang membawa genotip TT dan sebanyak 
0.84 bagi individu yang memiliki aiel T bagi varian ini. 
Sebaliknya, tabu ran genotip bagi G894T adalah 7 4.1% bagi homozigos liar 
(GG), 24.6% bagi heterozigos (GT) dan 1.3% bagi homozigos mutan (TT). Hanya lima 
individu daripada keseluruhan subjek kajian didapati membawa genotip mutan. Bila 
dikategorikan keseluruhan populasi kajian kepada dua kumpulan, didapati frekuensi 
GG, GT dan TI adalah 72.0%, 27.0% dan 1.0% bagi hipertensi dan 76.3%, 22.2% dan 
1.5% bagi kawalan. Di dalam kajian ini, secara amnya frekuensi bagi aiel G894 dan 
T894 adalah 85.5% dan 14.5% dikalangan penghidap hipertensi dan 87.4% dan 12.6% 
dikalangan subjek kawalan. Penganalisaan mengunakan analisis chi-kuasadua {X2) 
mendapati tiada perbezaan yang signifikan dicerap pada frekuensi genotip (x2=0.94, 
p=0.33) dan aiel <l=0.60, p=0.44) di antara kedua-dua kumpulan kajian. Risiko 
bandingan bagi hipertensi adalah sebanyak 1.25 bagi subjek yang membawa genotip 
TT dan sebanyak 1.17 bagi individu yang memiliki aiel T bagi varian ini. 
Di dalam men~ntukan frekuensi polimorfisme T594M bagi ~-ENaC didapati 
bahawa keseluruhan subjek kajian ini adalah merupakan jenis liar bagi varian ini. Tiada 
seorang pun dikalangan subjek kajian yang membawa genotip homozigos mutan 
ataupun heterozigos. Di andaikan bahawa varian T594M bagi ~-ENaC adalah jarang 
terdapat dikalangan populasi Melayu. 
xviii 
Analisis statistik yang dilakukan menggunakan Multiple Linear Regression 
(MLR) menunjukkan bahawa tekanan darah sistolik dan diastolik tidak berkolerasi 
secara signifikan dengan genotip f3-ENaC T594M, AGT M235T dan eNOS G894T di 
dalam kedua-dua kumpulan kajian. Genotip bagi setiap varian bukan merupakan faktor 
penentu bagi kedua-dua tekanan darah sistolik dan diastolik di dalam keseluruhan 
populasi kajian. Maka dapat disimpulkan bahawa varian polimorfik bagi calon-calon 
gen kajian bukanlah merupakan faktor penyebab utama bagi kejadian hipertensi di 
dalam populasi Melayu. 
Katakunci: Hipertensi, Melayu, gen angiotensinogen, gen epithelial sodium channel, 
gen endothelial nitric oxide synthase, polimorfisme gen 
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STUDIES TO DETERMINE THE PREVALENCE OF CANDIDATE GENE 
POLYMORPHISM FOR HYPERTENSION AMONG MALAYS 
ABSTRACT 
Hypertension or elevated arterial blood pressure is a substantial public health problem 
and is a major risk factor for many common causes of cardiovascular morbidity and 
mortality. Blood pressure is regulated by a variety of mechanisms that involve the 
products of several genetic loci and a number of environmental factors. "Human 
essential hypertension" is a multifactorial disorder that is complicated by the interaction 
of both genetic and an environmental factors. Research on the molecular genetics of 
human essential hypertension developed several years ago. One approach is to study 
candidate genes that may contribute to abnormal blood pressure because of their 
known effect on the cardiovascular system. 
Among the listed of candidate genes published for their known associations 
with hypertension, three of them were selected and their association with hypertension 
in the Malays was investigated in this thesis. The prevalence of these polymorphic 
variants within the specific candidate genes in the population was also determined. 
Polymorphisms studied were the T594M of the epithelial sodium channel (ENaC) gene, 
the M235T of the angiotensinogen (AGT) gene and the G894T of the endothelial nitric 
oxide synthase (eNOS) gene. A total of 398 DNA samples from 200 hypertensives and 
198 age- and sex- matched controls were analyzed in this genetic polymorphism study. 
Subjects recruited in this study were pure Malay for three generations. 
XX 
The frequency distribution of the M235T genotypes in the population was 3.5% 
for homozygous wild-type (MM}, 30.4% for heterozygous (MT) and 66.1% for 
homozygous mutant (TT). The frequency of the TT genotype was 63.5% in 
hypertensives and 68.7% in controls, respectively. The frequencies of the M235 and 
T235 alleles were 20.0% and 80.0% among the hypertensives and 17.4% and 82.6% 
among the controls. No significant difference was observed in genotype (x2=1.30, 
p=0.52) and allele <l=0.87, p=0.35) frequencies among the two study group. The odds 
ratio for hypertension is 1.01 for subjects carrying the TT genotype and 0.84 for those 
having T allele of the variant. 
In contrast, the distribution of genotypes for G894T was 74.1% for homozygous 
wild-type (GG), 24.6% for heterozygous (GT) and 1.3% for homozygous mutant (TT), 
respectively. Only five individuals from the overall study subjects were found to be 
carrying the mutant genotype. When categorized into two groups, it was found that the 
frequency of GG, GT and TT were 72.0%, 27.0% and 1.0% in hypertensives and 
76.3%, 22.2% and 1.5% in controls. In this study, the frequencies of the G894 and 
T894 alleles were 85.5% and 14.5% among the hypertensives and 87.4% and 12.6% 
among the controls, respectively. Using chi-square analysis, no significant difference 
was observed in genotype (x2=0.94, p=0.33) and allele <l=0.60, p=0.44) frequencies 
between both study groups. The odds ratio for hypertension is 1.25 for subjects 
carrying the TT genotype and 1.17 for those having allele T of the variants. 
In determining the prevalence of T594M polymorphism of the 13-ENaC, it was 
found that the overall study subjects are wild-type for this variant. None of the study 
subjects carried a homozygous mutant or heterozygous genotype. It is likely that 
T594M variant of the 13-ENaC gene is rare among Malay population. 
xxi 
Statistical analysis done using Multiple Linear Regression (MLR) shows that 
systolic and diastolic blood pressure were not correlated significantly with !3-ENaC 
T594M, AGT M235T and eNOS G894T genotype in both study groups. The genotype 
of each variant was not a predictor for both systolic and diastolic blood pressure in the 
overall study population. Hence, polymorphic variant of studied candidate genes is not 
likely to be a major factor causing hypertension in Malay population. 
Keywords: Hypertension, Malays, angiotensinogen gene, epithelial sodium channel 
gene, endothelial nitric oxide synthase gene, gene polymorphism. 
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1.1 Hypertension 
CHAPTER 1 
INTRODUCTION 
Hypertension or elevated arterial blood pressure is a substantial public 
health problem and is a major risk factor for many common causes of morbidity 
and mortality including stroke, myocardial infarction, congestive heart failure 
and end stage renal disease (Kannel, 2000, Mosterd et a/., 1999). Despite the 
important role of hypertension as a cause of disease, its pathogenesis remains 
largely unknown. Substantial efforts have been done to defining the 
pathogenesis of blood pressure variation. Epidemiologic studies have shown 
the impact of a variety of factors including age, gender and body mass index 
(Stanton et a/., 1982). Diet has also been implicated with salt, potassium and 
calcium suggested as important factor (Appel eta/., 1997). How these factors 
influence physiology to alter blood pressure has been the subject of extensive 
investigation. 
The difficulty in defining the causes of hypertension from physiologic 
studies alone has motivated the application of genetic approaches to 
hypertension. Identification of genes underlying blood pressure variation has the 
capacity to define primary physiologic mechanisms underlying this trait, thereby 
clarifying disease pathogenesis, identifying pathways and targets for therapeutic 
intervention, providing opportunity for preclinical diagnosis and allowing 
treatment tailored to underlying abnormalities in individual patients (Lifton eta/., 
2001) 
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In year 1999, the World Health Organization and the International 
Society of Hypertension (WHO-ISH) Guidelines Committee has published 
guidelines for management of chronically elevated blood pressure based on 
evidence from epidemiological studies and clinical trials. According to these 
guidelines, hypertension is defined as a systolic blood pressure (SBP) of 140 
mmHg or higher and/or a diastolic blood pressure (DBP) of 90 mmHg or greater 
(Table 1.1 ). The WHO-ISH also suggested few important areas of research to 
be focused in future. These include genetic studies on hypertension. 
In developed and developing countries alike, essential hypertension 
affects 25-35% of the adult population, and up to 60-70% of those beyond the 
seventh decade of life (Staessen et a/., 2003). Large population surveys in 
many countries (Burt eta/., 1995, Nissinen eta/., 1988) showed its prevalence 
varied from one to over 30 percent. A similar high prevalence was found in a 
previous national survey in 1986 as well as in smaller survey (Kandiah et a/., 
1980, Osman et a/., 1984) in Malaysia. The prevalence of hypertension in 
Malaysia was found to be between 14.0 to 24.1% (Ministry of Health, 1999). 
Results from the National Health and Morbidity Survey (1996) found a 
prevalence of 33% or an estimated of 2.6 million Malaysian adults aged 30 or 
older had hypertension (Table 1.2) (Lim and Morad, 2004). 
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Table 1.1: Definitions and classification of blood pressure levels (mmHg) 
according to JNC VI 
Boundaries 
Category 
Systolic Diastolic 
Optimal < 120 < 80 
Normal < 130 < 85 
High-normal 130-139 85-89 
Grade 1 hypertension (mild) 140- 159 90-99 
Subgroup : borderline 140-149 90-94 
Grade 2 hypertension (moderate) 160-179 100-109 
Grade 3 hypertension (severe) ~ 180 ~ 110 
Isolated systolic hypertension ~ 140 < 90 
Subgroup : borderline 140- 149 < 90 
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Table 1.2: Prevalence of hypertension in Malaysian adult population 
Ethnicity Sex N Prevalence Age adjusted * Estimated 
% (SE) prevalence population 
% (SE) (SE) 
All Both 21,391 32.9 (0.5) 32.9 (0.4) 2,577,044 (56200) 
Men 10,003 31.9 (0.6) 32.1 (0.5) 1 ,260,209 (33598) 
Women 11,388 33.9 (0.6) 33.5 (0.5) 1,316,834 (31264) 
Malay Both 9,656 33.5 (0.6) 33.5 (0.5) 1, 138,790 (34917) 
Men 4,502 29.9 (0.8) 30.0 (0.7) 496,390 (18062) 
Women 5,154 37.1 (0.8) 36.9 (0.7) 642,400 (20792) 
Chinese Both 5,978 33.1 (0.8) 31.1 (0.6) 791 ,090 (32277) 
Men 2,746 35.2 (1.1) 34.0 (1.0) 420,028 (18848) 
Women 3,232 30.9 (1.0) 28.2 (0.8) 371 ,062 (17080) 
Indian Both 1,467 30.8 (1.3) 31.7 (1.3) 186,257 (14206) 
Men 679 34.9 (1.8) 35.5 (1.9) 103,965 (8597) 
Women 788 26.9 (1.7) 27.9 (1.5) 82,292 (7156) 
Other Both 3,194 34.3 (1.0) 34.8 (0.9) 237,413 (12338) 
indigenous Men 1,482 32.2 (1.3) 32.8 (1.3) 112,073 (6268) 
Women 1,712 36.4 (1.3) 36.8 (1.2) 125,340 (6983) 
* Age-adjusted to the 1996 Malaysian population 
Adapted from : (Lim and Morad, 2004) 
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1.2 Genetics of hypertension 
'Hypertension' is an arbitrary definition and not a quantitative trait that 
appears relatively late in life. When discussing about the genes involved in 
hypertension, nothing much is known about their mode of transmission, their 
quantitative effects on blood pressure, their interaction with other genes, or their 
modulation by environmental factors. Parameters such as ethnicity and body 
weight increase the genetic heterogeneity and the difficulty of replication from 
one study to another (Corvol eta/., 1999). 
There is substantial evidence for genetic influence on blood pressure. 
Twin studies show greater concordance of blood pressures in monozygotic than 
dizygotic twins (Feinleib et a/., 1977) and population studies demonstrate 
greater similarity of blood pressure within families than between families 
(Longini et a/., 1984 ). This familial aggregation is not simply attributable to share 
environmental effects since adoption studies show greater concordance of 
blood pressure among biological siblings than adoptive siblings living in the 
same household (Biron eta/., 1976, Perusse eta/., 1989). Finally, that single 
genes can impart large effects on blood pressure is demonstrated by rare 
Mendelian forms of high and low blood pressure (Lifton, 1996). 
Despite this evidence of a large effect of inheritance on blood pressure, 
these same studies suggest that blood pressure is commonly multifactorial in 
determination since (i) blood pressure does not typically segregate in families in 
a fashion consistent with Mendelian transmission and (ii) a variety of other 
factors such as salt intake, age, gender and body mass can influence blood 
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pressure. It is popular to presume that the blood pressure in individual patients 
is due to the combined effects of variation at a number of blood pressure-
determining loci, environmental factors and demographic factors (Figure 1.1) 
(Lifton, 1995). 
Hypertension has been termed by geneticists as 'a polygenic disorder 
that is a result of manifested phenotype that is substantially affected by the 
environment' (Hamet, 1996). Based on the mode of inheritance, hypertension 
can be classified as either Mendelian hypertension (monogenic forms of 
hypertension) or essential hypertension (polygenic forms of hypertension). 
Mendelian forms of hypertension result from a single defective gene, and 
individuals harboring such mutated genes transmit them in a dominant or 
recessive manner. In contrast, essential hypertension occurs as a consequence 
of a complex interplay of a number of genetic alterations and environmental 
factors, and therefore does not follow a clear pattern of inheritance, but exhibits 
familial aggregation of cases. 
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Gene2 ~ Gene3 
~el \ / / Gene4 I~ \ 
Environmental Factor 1 -+ Blood Pressure +-- Environmental Factor 2 
/ t ~~ 
Gender 
Age 
Figure 1.1: Multifactorial model of blood pressure determination, demonstrating 
the potential influence of genes, environmental factors and 
demographic factors on blood pressure. 
(The potential interaction of these determining factors is 
represented by arrows linking different determinants). 
Adapted from : (Lifton, 1995) 
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1.2.1 Monogenic forms of hypertension 
Considerable progress has been made during the past few years towards 
unraveling the molecular genetics of some rare, or extremely rare, monogenic 
forms of hypertension. Although it is widely accepted that blood pressure is a 
polygenic trait, it is recognized that a small proportion of familial forms of 
hypertension are inherited as single gene disorders. Molecular genetic studies 
have identified mutations in eight genes that cause Mendelian forms of 
hypertension and nine genes that cause Mendelian forms of hypotension in 
humans (Lifton eta/., 2001 ). These genes typically impart very large effects on 
blood pressure (Table 1.3). However, lessons learned from the monogenic 
forms of hypertension have highlighted what the clinical benefits could be if 
susceptibility genes were to be identified also for essential hypertension. 
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Table 1.3: Mendelian forms of blood pressure dysregulation 
Mode of Effect on blood 
Syndrome Chromosome inheritance * pressure 
Glucocorticoid-remediable 8q22 ADI Increased 
aldosteronism (GRA) 
Apparent mineralocorticoid 16q22 ARI Increased 
excess (AME) 
Hypertension exacerbated 4q31.1 ADI Increased 
by pregnancy 
Hypertension with 12p11.2-p12.2 ADI Increased 
brachydactyly 
Steroid 11 P-hydroxylase 8q21 ARI Increased 
deficiency 
Steroid 17a-hydroxylase 10q24.3 ARI Increased 
deficiency 
Gordon's syndrome 1q31-q42 ADI Increased 
12p13 
17q21-q22 
Liddle's syndrome 16p12-p13 ADI Increased 
Gitelman's syndrome 16q13 ARI Decreased 
Bartter's syndrome 15q15-q21 ARI Decreased 
11q24 
1q36 
Aldosterone synthase 8p21 ARI Decreased 
deficiency 
Steroid 21-hydroxylase 6p21.3 ARI Decreased 
deficiency 
* ADI - autosomal dominant mode of inheritance; 
ARI - autosomal recessive mode of inheritance 
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1.2.2 Essential hypertension 
Essential hypertension, or hypertension of unknown cause, accounts for 
more than 90% of cases of hypertension. It refers to a lasting increase in blood 
pressure with heterogeneous genetic and environmental causes (Staessen et 
a/., 2003). Evidence suggests that genes may contribute to 30% of the variation 
of blood pressure. However, the number of genes involved or the model of 
interaction with other genes or environmental risk factors is unknown (Williams 
et a/., 1991 ). The multifactorial, polygenic nature and complex etiology of 
essential hypertension has made the study of this disease difficult. The resulting 
phenotypes can be modulated by various environmental factors, thereby 
altering the severity of blood pressure elevation and the timing of hypertension 
onset. 
The prevalence of essential hypertension is 3.8 times greater in 
individuals with a positive family history of hypertension, suggesting that 
hypertension has a genetic component (Su and Menon, 2001 ). There is less 
evidence for heritability in older age groups (Hunt eta/., 1986). Although familial 
aggregation of essential hypertension is well established, inheritance does not 
follow a simple Mendelian pattern. A large proportion of the phenotypic variation 
in blood pressure appears to be inherited as polygenic trait. Therefore, the 
expression of hypertension in any individuals is likely to be the result of a 
number of genetic alternations. 
The effects of individual genes can be independent and additive, or can 
be more complex, characterized by phenomena such as epistasis (i.e. the 
interactive effect of multiple genes on a phenotype) or pleiotropy (i.e. the 
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simultaneous effects of a single gene on multiple phenotypes) (Schork et a/., 
1996). Furthermore, environmental factors affect the expression of gene 
function (Hamet, 1996). Therefore, it is difficult to demonstrate a statistically 
significant correlation between occurrence of a particular gene or allelic variant 
and the hypertensive phenotype in a patient population. 
1.2.2.1 Identification of Susceptibility Loci 
Discovering the major susceptibility locus can be the key to advances in 
understanding the causes of a disease (Gambaro eta/., 2000). Owing to these 
uncertainties, it is difficult to determine the optimal approach to identification of 
susceptibility loci affecting blood pressure in humans. A number of alternative 
approaches can be considered at present. The identification of susceptibility loci 
can be pursued by different approaches: in families, either by segregation 
analysis, which can suggest the existence of a major locus and at least in part 
define its properties; or by linkage analysis of candidate genes or markers to 
localize a gene, followed by positional cloning; and in the general population by 
association studies in homogeneous populations. 
Segregation and linkage analysis face difficulties with non-Mendelian 
conditions; indeed the former is very sensitive to biases, whereas the latter 
requires the specification of a precise genetic model, including disease gene 
frequency and the penetrance of each genotype. Therefore, population 
association studies are mostly used in identification of susceptibility loci 
(Gambaro eta/., 2000). 
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1.2.2.2 Association and linkage studies in essential hypertension 
The study of human essential hypertension can be carried out using two 
basic molecular genetic approaches, association and linkage analysis 
(Davidson eta/., 1995, Lander and Schork, 1994, Luft, 1998). Both approaches 
require the detection of polymorphic markers such as bi-allelic restriction 
fragment length polymorphisms and variable nucleotide tandem repeats. These 
two approaches are not mutually exclusive, but can be merged into a single 
analytical method, such as transmission or disequilibrium test (TOT) (Spielman 
and Ewens, 1996). Each has advantages and disadvantages depending on 
situations tested. 
Association studies test whether a particular allele occurs at higher 
frequency among affected when compared to unaffected individuals and is 
generally restricted to a genomic region or a variant being tested. This approach 
is heavily dependent on matching affected with unaffected subjects. If a 
significant association emerges, the polymorphism itself is either in the 
susceptibility locus or in linkage disequilibrium with the susceptibility locus. In 
both cases, it should enable detection of people at risk of developing a certain 
disease or complications (Gambaro eta/., 2000). 
Genome-wide linkage studies for complex traits such as essential 
hypertension are problematic and require careful study design. This is because 
each variant individually contributes only modestly to risk of disease. A positive 
result using a linkage approach which generally tests related individuals, will 
implicate a region of genomic DNA containing a large number of genes, of 
which the causative gene for a particular disease will still have to be identified 
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(Lee eta!., 2000). Improved techniques in genome-wide linkage analysis have 
enabled a search for genes that contribute to the development of essential 
hypertension in the population (Oparil eta/., 2003). 
The above association and linkage studies have broken substantial 
ground and have yielded highly promising results suggesting a number of 
candidate genes and genomic regions that need further investigation as 
contributors to blood pressure variation. At the same time, some inconsistencies 
in the results and difficulties of replication in some studies illustrate a number of 
potential problems inherent in most genetic epidemiological studies of complex 
disorders (Timberlake eta/., 2001 ). 
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1.2.2.3 Insights from Animal Models 
An alternative approach of studying hypertension is based on the co-
segregation of phenotypes using experimental crosses derived from genetically 
hypertensive and control rat strains (Lee et a/., 2000). Rat models of 
hypertension have been developed and studied over many generations. Their 
complete genetic heterogeneity, large number of progeny, the ability to produce 
large genetic crosses and to provide tight control over environmental influences 
permit the dissection of complex traits such as hypertension (Table 1.4)(Lander 
and Schork, 1994, Smirk and Hall, 1958). 
/ 
Genetic models of experimental hypertension developed to approximate 
the pathogenesis of human hypertension include the spontaneously 
hypertensive rat (SHR), the SHR-stroke-prone strain, Lyon hypertensive and 
normotensive rat strains, Milan hypertensive and normotensive rat strains and 
Dahl salt sensitive rat strains (Bohr and Dominiczak, 1991 ). These models differ 
in genetics, cellular alternations and neurohumoral mechanisms. However, they 
all share the same feature of spontaneous development of hypertension under 
appropriate conditions. The two most commonly studied are the SHR and Dahl 
sensitive and resistant strains. 
Studies of gene interactions can be performed in these animal models, 
and the use of congenic animals constitutes a power tool to isolate and test 
specific chromosome regions in various genetic backgrounds (Kato, 2002). In 
addition, genes predisposing to hypertension in animal models may also be 
involved in the etiology of human hypertension, and hence the regions of 
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homology, or more directly the genes implicated in animal models, can be 
considered candidate regions or genes to be explore in human disease. 
As with any experimental model, there has been intense debate over the 
applicability of rat models to human hypertension. Rat chromosome 10 contains 
two blood pressure quantitative trait loci (QTL) (Hilbert eta!., 1991, Jacob eta/., 
1991) and is syntenic to human chromosome 17. Linkage of markers with 
hypertension has been found on human chromosome 17 (Baima et a/., 1999, 
Julier et a/., 1997). These studies provide some support for comparative 
mapping as a method of identifying candidate regions for the human disorder. 
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Table 1.4: Genetic analysis of hypertension in inbred rats and humans 
Expected number of susceptibility 
genes 
Heritability of hypertension 
Environmental factors 
Onset of hypertension 
Genetic homogeneity 
Reproducibility of BP 
measurement 
Analytical approaches 
QTL - quantitative trait loci 
Adapted from : (Kato, 2002) 
Inbred rats 
Several genes with 
major genetic effects 
-60% 
Controllable 
Early age 
High (inbred) 
Relatively good 
QTL mapping in 
experimental crosses 
Development of 
congenic strains 
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Humans 
unknown 
30-40% 
Uncontrollable 
Advances age 
Low (outbred) 
Relatively poor 
Linkage analysis 
(eg. affected sib-pairs) 
Association study 
(unrelated subjects) 
1.3 Genome-wide Scan 
Another major strategy for identifying loci contributing to a complex trait 
is genome-wide scanning. This involves genotyping family members using 
highly polymorphic markers spaced at regular interval (10-30 eM) across the 
entire genome. Each of the markers is then tested for linkage with the trait or 
disease of interest to identify genomic regions that may harbor trait-influencing 
loci (Timberlake eta/., 2001 ). There are now many publications describing the 
results of genome-wide scans for genes controlling blood pressure (Table 1.5). 
The majority have reported numerous chromosomal regions with suggestive 
evidence of linkage (Garcia et a/., 2003, Samani, 2003). These studies lay 
important foundations for large-scale human hypertension research and 
suggest a number of promising genomic regions that may contain blood 
pressure loci. 
Genome-wide scans for hypertension do not presume any prior 
knowledge of the mechanisms underlying blood pressure regulation. Genome-
wide scanning followed by positional cloning has recently proven successful in 
identifying disease susceptibility genes for two other complex diseases; type 2 
diabetes mellitus and Crohn's disease (Horikawa et a/., 2000, Hugot et a/., 
2001 ). So far, no primary hypertension susceptibility gene has been identified 
by this method but a number of promising chromosomal regions showing 
evidence of linkage to hypertension or blood pressure variation have been 
identified (Krushkal eta/., 1999, Levy eta/., 2000, Xu eta/., 1999). 
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Each genome scan reported differs in numbers, ethnicity, family types, 
design and the phenotyping strategy, where there are studies using blood 
pressure as a quantitative phenotype while others using hypertension (Mein et 
a/., 2004). The use of different markers, study designs and poor precision with 
linkage data make it difficult to know if the studies have found the same gene. 
The inconsistency of results among these human genome-wide studies may 
reflect differences in the ethnic composition and selection criteria for the study 
population. Also, these results may underscore the heterogeneous and 
polygenic nature of hypertension (Timberlake eta/., 2001 ). 
In future, a hybrid approach has been suggested: genome-wide scans on 
one hand is to identify new susceptibility genes and disease-causing haplotype, 
and on the other hand will provide detailed studies of overall sequence variation 
of candidate genes in order to understand the underlying functional mechanism. 
The challenge now is to identify which of these loci are genuine and it will be the 
results of fine mapping or grid tightening in the first instance that will yield this 
information (Me in et a/., 2004 ). 
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Table 1.5: Genome-wide scan for blood pressure loci in human 
Author Chromosome Markers Potential candidate genes 
Krushkal et a/. 6 0681009 Estrogen receptor 
(1999) 15 0158652 Aminopeptidase 
5 0581471 Alpha 1 B andrenoergic receptor 
2 0281788 Sodium-calcium exchanger 1 
Xu eta/. (1999) 11 01182019 Angiotensin receptor like 1 
17 01781303 Pseudohypoaldosteronism type II 
3 0382387 A TPase Ca2+ transporting 
membrane 
16 01683396 Thiazide-sensitive NaCI co-
transport 
15 0158203 Insulin-like growth factor 1 
15 0158657 Cholinergic receptor 
Adapted partially from: (Timberlake eta/., 2001) 
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1.4 Specific candidate genes in hypertension 
Despite major advances during the past few years in biotechnology and 
bioinformatics, the classical candidate gene approach continues to be the most 
prevalent approach in the search for the genetic basis of hypertension. The 
candidate gene approach typically compares the prevalence of hypertension or 
the level of blood pressure among individuals of contrasting genotypes at 
candidate loci in pathways known to be involved in blood pressure regulation 
(Oparil eta/., 2003). The contribution of candidate genes to the pathophysiology 
of hypertension is continuing to be tested mostly using association studies in 
humans, and also using physiological and pharmacological interventional 
studies in animal models and in genetically modified strains (Yagil and Yagil, 
2005). 
Candidate genes are selected because of their logical or already 
established effect on cardiovascular and renal function, and on the basis of the 
known pathophysiology of essential hypertension. Thus, candidate genes for 
essential hypertension have been suggested by the elucidation of the molecular 
genetics of rare monogenic forms of hypertension, such as Liddle's syndrome 
(Shimkets eta/., 1994). A variety of candidate genes have been investigated, 
including loci involving the renin-angiotensin-aldosterone system (RAAS}, 
epithelial sodium channel (ENaC), the renal kallikrein-kinin system, a-adducin 
and others involving lipoprotein metabolism, hormone receptors, and growth 
factors (Figure 1.2). 
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The study of candidate genes, which assumes that a given gene or a 
group of genes involved in a specific function might contribute to blood pressure 
variation, has resulted in conflicting results (Lee eta/., 2000). Even though the 
candidate gene approach is widespread and the list of candidate genes for 
hypertension is increasing, there is still a problem with this strategy in the 
mission to unwind the complexity of hypertension. The initiative and efforts 
invested in the candidate gene approach appear to have been sporadic and 
uncoordinated, resulting in a long list of candidate genes that are not 
necessarily related to one another (Table 1.6). A more favorable view of the 
candidate gene approach is that the genetic basis of hypertension is analogous 
to a huge puzzle and the candidate genes, are the individual pieces in that 
puzzle (Yagil and Yagil, 2005). 
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Figure 1.2: Mutations and polymorph isms altering blood pressure in humans. 
(All the genes involved directly or indirectly in the control of renal 
sodium reabsorption. The mutations have been found in 
monogenic human diseases that cause disorders of blood pressure 
regulation). 
Adapted from : (Warnock, 2001) 
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Table 1.6: Partial list of candidate genes tested for an association with 
hypertension 
Candidate gene 
Renin-angiotensin-aldosterone system related 
1. Angiotensinogen 
2. Angiotensin-converting enzyme 
3. Angiotensin II receptor 1 
4. Aldosterone synthase 
Non-RAAS related 
1. Peroxisome proliferator-activated receptor y 
2. Insulin receptor substrate 1 
3. Serine-threonine kinase with no lysine (K)1 
4. Serine-threonine kinase with no lysine (K)4 
5. Lipoprotein lipase 
6. 133 subunit of G proteins 
7. Hepatocyte growth factor 
8. Solute carrier family 4, member 4 
a2s-Adrenoreceptor 
1. Potassium large conductance calcium activated channel, 
subfamily M, beta member 1 
Thromboxane 
1. Solute carrier family 6 (neurotransmitter transporter), 
member 18 
2. Endothelin receptor type A 
3. FK506-binding protein 1 8 
4. Adenosine receptor A 1 
5. Adenosine receptor A2 
6. Epithelial sodium channell31 subunit 
7. Epithelial sodium channel y1 subunit 
Adducin 
1. G protein-coupled receptor kinase 2 
2. Protein tyrosine phosphatase, non receptor type 1 
3. 1 Hydroxysteroid dehydrogenase-1, f} -3-13 
4. Uncoupling protein 2 
5. Insulin-like growth factor 1 receptor 
6. Myocyte specific enhancer factor 2A 
7. Paired basic amino acid-cleaving enzyme 4 
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Abbreviation 
RAAS 
AGT 
ACE 
AT1R 
CYP1182 
PPARy 
IRS-1 
WNK1 
WNK4 
LPL 
GNB3 
HGF 
SLC4A4 
KCNMB1 
XT2 
EDNRA 
FKP18 
ADORA1 
ADORA2 
SCNN18 
SCNN1G 
GRK4 
PTP18 
HSD38 
UCP2 
IGFIR 
MEF2A 
PACE4 
1.4.1 Epithelial Sodium Channel (ENaC) 
Among many factors affecting the blood pressure variation, the kidney 
plays an important role in the long-term regulation of sodium balance, blood 
volume, and blood pressure via pressure diuresis and pressure natriuresis 
(Guyton eta/., 1972, Liard eta/., 1974). It has been known for a long time that 
the kidneys play a vital role in the long-term control of blood pressure (Guyton 
eta/., 1994), and recently this concept has been reinforced by the identification 
of the molecular defects in monogenic forms of hypertension (Lifton, 1996). The 
kidney regulates extracellular fluid volume by tightly controlling sodium balance. 
There are direct and indirect relationships between sodium balance, the 
extracellular fluid volume and blood pressure. 
Sodium is the major ion of the extracellular fluid, and the total amount of 
exchangeable sodium therefore determines both the extracellular fluid volume 
and blood pressure. Guyton and colleagues have argued that hypertension 
cannot be sustained without the active participation of the kidney, because 
elevated renal perfusion pressure leads to water diuresis, returning blood 
pressure to normal levels (Guyton, 1991). Increased generation of the adrenal 
hormone aldosterone is a major mechanism in the preservation of salt and 
water in response to sodium used. However, in the presence of a sustained 
large salt intake, body fluid volumes do not increased indefinitely; normally, 
urinary sodium excretion is increased to match the higher sodium intake, 
thereby preventing overt and dangerous expansion of the extracellular fluid 
volume. Modulation of renal sodium excretion is a key process in the 
maintenance of sodium balance. 
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